In a cohort of ICC patients, tumors with high levels of ALKBH5 also demonstrated strong PD-L1 expression [114], suggesting that ALKBH5 plays a role in creating an immunosuppressive microenvironment. Here, ALKBH5 is linked to intrahepatic cholangiocarcinoma.